APA (7th ed.) Citation

Kunimasa, K., Kawamura, T., Tamiya, M., Inoue, T., Kuhara, H., Nishino, K., & Kumagai, T. (2021, December). Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema. Thoracic Cancer.

Chicago Style (17th ed.) Citation

Kunimasa, Kei, Takahisa Kawamura, Motohiro Tamiya, Takako Inoue, Hanako Kuhara, Kazumi Nishino, and Toru Kumagai. "Capmatinib Successfully Overcomes Tepotinib‐induced Intolerable Peripheral Edema." Thoracic Cancer Dec. 2021.

MLA (9th ed.) Citation

Kunimasa, Kei, et al. "Capmatinib Successfully Overcomes Tepotinib‐induced Intolerable Peripheral Edema." Thoracic Cancer, Dec. 2021.